| Property | Value |
|---|
|
?:abstract
|
-
Objective: The COVID-19 pandemic has placed increased strain on healthcare systems worldwide with enormous reorganisation undertaken to support € COVID-centric\' services Non-COVID-19 admissions reduced secondary to public health measures to halt viral transmission We aimed to understand the impact of the response to COVID-19 on the outcomes of upper gastrointestinal (UGI) bleeds Design/methods: A retrospective observational multicentre study comparing outcomes following endoscopy for UGI bleeds from 24 March 2020 to 20 April 2020 to the corresponding dates in 2019 The primary outcome was in-hospital survival at 30 days with secondary outcomes of major rebleeding within 30 days postprocedure and intervention at the time of endoscopy Results: 224 endoscopies for 203 patients with UGI bleeds were included within this study 19 patients were diagnosed with COVID-19 There was a 44 4% reduction in the number of procedures performed between 2019 and 2020 Endoscopies performed for UGI bleeds in the COVID-19 era were associated with an adjusted reduced 30-day survival (OR 0 25, 95% CI 0 08-0 67) There was no increased risk of major rebleeding or interventions during this era Patients with COVID-19 did not have reduced survival or increased complication rates Conclusion: Endoscopy for UGI bleeds in the COVID-19 era is associated with reduced survival No clear cause has been identified but we suspect that this is a secondary effect of the response to the COVID-19 pandemic Urgent work is required to encourage the public to seek medical help if required and to optimise patient pathways to ensure that the best possible care is provided
|
|
is
?:annotates
of
|
|
|
?:creator
|
|
|
?:journal
|
-
Frontline_Gastroenterology
|
|
?:license
|
|
|
?:publication_isRelatedTo_Disease
|
|
|
is
?:relation_isRelatedTo_publication
of
|
|
|
?:source
|
|
|
?:title
|
-
Reduced survival after upper gastrointestinal bleed endoscopy in the COVID-19 era is a secondary effect of the response to the global pandemic: A retrospective cohort study
|
|
?:type
|
|
|
?:who_covidence_id
|
|
|
?:year
|
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}